Alimera Sciences, Inc.

57
Hold
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals: Major
  • ISIN: US0162592028
USD
5.54
-0.01 (-0.18%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Alimera Sciences, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
No of Months
12
12
12
12
12
12
Profit Before Tax
-20.00
-18.00
-3.00
-5.00
-10.00
-16.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-15.00
2.00
-1.00
-1.00
0.00
-4.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-14.00
-9.00
-3.00
-2.00
-4.00
-11.00
Cash Flow from Investing Activities
-75.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Financing Activities
96.00
0.00
9.00
3.00
0.00
0.00
Net Cash Inflow / Outflow
6.00
-11.00
5.00
1.00
-3.00
-11.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Alimera Sciences, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
-20.047
-105.624
85.00
81.02%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-15.801
2.52
-17.00
-727.02%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-14.261
-84.305
70.00
83.08%
Cash Flow from Investing Activities
-75.532
0
-75.00
0.00%
Cash Flow from Financing Activities
96.499
113.805
-17.00
-15.21%
Net Cash Inflow / Outflow
6.786
29.5
-23.00
-77.00%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.08
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'23
stock-summary

YoY Growth in year ended Dec 2023 is -42.97% vs -209.40% in Dec 2022

Dec'23
Dec'22
Change(%)
Cash Flow from Operating Activities
-14.26
-9.97
-42.97%